Dilution of per-share value from the exercise of stock options
First written in FY2016. 18 of 28 entries say "Materialised", first in FY2018-Q2. Latest entry: FY2025.
Money Forward moved to the "Worse" side of this theme in 2017, 3 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
30 other companies' latest entry also says "Worsened".
- FY2025WorsenedAnnual report
「2,157,600 shares underlying the 13th Series Stock Acquisition Rights and 5,000 shares underlying the 15th Series Stock Acquisition Rights」
While the 13th and 15th Series Stock Acquisition Rights established a total of 2,162,600 potential shares, 194,960 shares were also issued during the fiscal year through the exercise of stock acquisition rights. - FY2025-H1WorsenedAnnual report
「(2) 14th Series Stock Acquisition Rights (Resolution of the Board of Directors dated 25 March 2025) Number of shares underlying the stock acquisition rights (shares)* 79,200 (Note) 1」
The 14th Series Stock Acquisition Rights added 79,200 potential shares for future issuance. Share issuance through the exercise of stock acquisition rights also continued during the interim consolidated accounting period. - FY2024WorsenedAnnual report
「2,157,600 common shares (100 shares per stock acquisition right)」
The 13th Series Stock Acquisition Rights were issued after the end of the fiscal year, newly establishing 2,157,600 potential shares for future issuance. - FY2024-Q2MaterialisedAnnual report
「2 March 2024–18 April 2024 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 20 April 2024–31 May 2024 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, the number of shares outstanding increased by 104,400 and 20,120 through the exercise of stock acquisition rights, and potential dilution continued to occur through actual share issuance. - FY2024-Q1MaterialisedAnnual report
「1 December 2023–29 February 2024 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. Between 1 March 2024 and 31 March 2024, the total number of shares outstanding increased by 104,400 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥56.151 million.」
During the quarter, the number of shares outstanding increased by 179,560 through the exercise of stock acquisition rights, and increased by a further 104,400 in March 2024 before the filing date. Potential dilution continued to occur through actual share issuance. - FY2023WorsenedAnnual report
「2028 Euro-yen Convertible Bonds with Stock Acquisition Rights, subject to call provisions (issued 18 August 2023)」
The convertible bonds with stock acquisition rights totaling ¥12,000 million established 1,535,705 common shares subject to conversion, adding to the shares subject to potential dilution. - FY2023-Q3WorsenedAnnual report
「2028 Euro-yen Convertible Bonds with Stock Acquisition Rights, subject to call provisions (issued 18 August 2023)」
Convertible bonds with stock acquisition rights totaling ¥12,000 million were issued, establishing 1,535,705 common shares subject to conversion. The number of shares subject to potential dilution increased. - FY2023-Q2MaterialisedAnnual report
「1 March 2023–6 April 2023 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 8 April 2023–31 May 2023 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the quarter, the number of shares outstanding increased by 42,120 and 60,600 through the exercise of stock acquisition rights, and potential dilution continued to occur through actual share issuance. A further 13,800 shares had been issued by the filing date. - FY2023-Q1MaterialisedAnnual report
「23 February 2023–28 February 2023 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the number of shares outstanding increased by 73,600 through the exercise of stock acquisition rights, and dilution continued to occur through actual share issuance. In addition, 1,166,000 potential shares were established under the 12th Series Stock Acquisition Rights. - FY2022MaterialisedAnnual report
「The increase in common shares comprised 259,400 shares issued upon the exercise of stock acquisition rights and 186,675 shares issued as restricted stock compensation.」
The issuance of 259,400 shares through the exercise of stock acquisition rights and 186,675 shares as restricted stock compensation resulted in continued dilution. - FY2022-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From June to August 2022, the number of shares outstanding increased by 127,440 through the exercise of stock acquisition rights, and increased by a further 12,600 in September. Potential dilution has continued to occur through actual share issuance. - FY2022-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the number of issued shares increased by 12,000 through the exercise of share acquisition rights, followed by a further increase of 36,560 by the filing date. Dilution continued to materialize through actual share issuances. - FY2021MaterialisedAnnual report
「The increase in common shares consisted of 23,851,218 shares from a stock split, 5,000,000 shares from the issuance of new shares through a public offering to overseas investors, 551,080 shares from the issuance of new shares upon the exercise of share acquisition rights, and 128,944 shares from the issuance of new shares as restricted stock compensation.」
The issuance of 551,080 new shares upon the exercise of share acquisition rights actually occurred, and dilution continued. - FY2021-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From June through August 2021, the number of issued shares increased by a total of 171,600 through the exercise of share acquisition rights, and potential dilution continued to materialize through actual share issuances. - FY2021-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the quarter, the number of issued shares increased by a total of 127,920 through the exercise of share acquisition rights, and potential dilution continued to materialize through actual share issuances. - FY2021-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the quarter, the number of issued shares increased by 109,760 through the exercise of share acquisition rights, and increased by a further 42,560 in March 2021, with potential dilution continuing to materialize through actual share issuances. - FY2020-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the quarter, the number of issued shares increased by a total of 65,520 through the exercise of share acquisition rights, and potential dilution continued to materialize through actual share issuances. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the number of issued shares increased by a total of 60,940 through the exercise of share acquisition rights, and potential dilution continued to materialize through actual share issuances. - FY2019-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between June and August 2019, the total number of issued shares increased by 240,260 through the exercise of share acquisition rights, and increased by a further 1,760 in September. Potential dilution continued to materialize through actual share issuances. - FY2019-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the second quarter, the number of issued shares increased by a total of 68,060 through the exercise of share acquisition rights, and increased by a further 260 in June 2019. Potential dilution continued to materialize through actual share issuances. - FY2019-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the number of issued shares increased by a total of 60,560 through the exercise of share acquisition rights, resulting in potential dilution through an actual share issuance. - FY2018-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the third quarter, the number of issued shares increased by 2,900 through the exercise of share acquisition rights, resulting in potential dilution through an actual share issuance. - FY2018-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the second quarter, the number of issued shares increased by 64,640 through the exercise of share acquisition rights, resulting in an actual issuance of shares from potential dilution. - FY2018-Q1WorsenedAnnual report
「11th Series of Share Acquisition Rights (resolution of the Board of Directors dated 15 January 2018)」
The 11th series of share acquisition rights was issued in an amount of 3,200, covering 320,000 common shares, adding to the potential dilution. - FY2017WorsenedAnnual report
「As of the end of the month preceding the filing date of this report, the number of potential shares from share acquisition rights was 2,227,380, equivalent to 11.6% of the 19,197,760 issued shares.」
The company disclosed 2,227,380 potential shares and subsequently resolved to issue share acquisition rights covering 320,000 common shares, adding to the shares subject to dilution. - FY2017-Q3WorsenedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
The 10th series of share acquisition rights was issued, covering 4,000 common shares, with an exercise period from 23 June 2020 to 22 June 2026, thereby specifying the potential dilution. - FY2017-Q1WorsenedAnnual report
「We will issue share acquisition rights as stock options to our directors and employees free of charge, with the aim of further increasing their motivation and morale and strengthening their commitment to business expansion as we seek to increase corporate value over the medium to long term.」
Resolutions were passed to add potential shares through the 8th, 9th and 10th series of share acquisition rights, increasing the shares subject to potential dilution. - FY2016First statedAnnual report
「As of the filing date of this document, the number of potential shares from share acquisition rights was 120,962, equivalent to 14.5% of the 833,085 issued shares.」
The number of potential shares and their percentage of total issued shares were quantified, disclosing the potential for dilution upon future exercise.